02-24 | |
Does ‘benign NMOSD’ exist? A case series from a national referral centre | |
Pakeeran Siriratnam | |
Walton Centre, NHS Trust | |
Download PDF – 02-24 | |
The Abstract | |
Abstract Body | Introduction: Most patients with neuromyelitis optica spectrum disorder (NMOSD) harbour antibodies to aquaporin-4 (AQP4-IgG). AQP4-IgG NMOSD typically follows a relapsing disease course, resulting in significant stepwise disability accumulation with each relapse. Previous studies have demonstrated that patients with NMOSD experience disabling relapses several years after achieving disease stability if they discontinue immunosuppression, necessitating lifelong immunosuppression. |
Additional Authors | |
Chiara Rocchi | |
Emily Gibbons | |
Saif Huda | |
Additional Institutions | |
Monash University , Department of Neuroscience, Melbourne, Australia |
02-24 – Does ‘benign NMOSD’ exist? A case series from a national referral centre
Written by
in